Peter Hirth - 26 May 2022 Form 4 Insider Report for IO Biotech, Inc. (IOBT)

Role
Director
Signature
/s/ Brian Burkavage, Attorney-in-Fact for Peter Hirth
Issuer symbol
IOBT
Transactions as of
26 May 2022
Net transactions value
$0
Form type
4
Filing time
31 May 2022, 19:42:07 UTC
Previous filing
04 Nov 2021
Next filing
03 Jun 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IOBT Stock Option (Right to Buy) Award $0 +23,885 $0.000000 23,885 26 May 2022 Common Stock 23,885 $4.85 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These options vest on May 26, 2023, subject to the reporting person's continued service through the applicable vesting date, and subject to 100% acceleration upon a change of control.